Funding
← Back to your selection

Vida Ventures

Activity from announced rounds

All recorded activity
Rounds participated in
6
Confirmed lead rounds
0
5 roles undisclosed
New companies
5
First participation on record · 1 follow-on
Funding in participating rounds
$507M
6 disclosed · full round size, not this investor’s share

By stage

Series B3
Series A2
Series C+1

By primary sector

Biotech5
Healthtech1

By country

United States5
Denmark1

Rounds

6 in all activity
Soufflé Therapeutics

Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.

$135MSeries B
Participant
InduPro

Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease

$77MSeries B
Role not disclosed
SonoThera

Develops ultrasound-mediated nonviral genetic medicines

$125MSeries B
Role not disclosed
Adcendo

Adcendo develops antibody-drug conjugates that deliver cancer drugs to tumor-associated targets, with clinical programs in solid tumors and soft tissue sarcoma.

$75MSeries C
Role not disclosed
Poplar Therapeutics

Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions

$45MSeries A+
Role not disclosed
Poplar Therapeutics

Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions

$50MSeries A
Role not disclosed